Stock Track | Vera Therapeutics Soars 5.21% on Buy Rating and Price Target Increase from TD Cowen

Stock Track

03-06

Vera Therapeutics, Inc. (VERA) stock soared 5.21% in intraday trading on Wednesday, following a Buy rating and price target increase from TD Cowen analyst Ritu Baral.

In a research report released today, Baral maintained a Buy rating on VERA and raised the price target, citing the company's promising drug pipeline and potential for significant growth. The analyst's positive outlook on VERA's prospects has boosted investor confidence, driving the stock price higher.

Vera Therapeutics is a biopharmaceutical company focused on developing innovative therapies for various diseases. The company's drug candidates have shown promising results in clinical trials, leading analysts to be optimistic about their future success.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1132052591"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1132052591\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/1132052591?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-03-06 04:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1132052591","market":"us","top_or_hot":-1,"title":"Stock Track | Vera Therapeutics Soars 5.21% on Buy Rating and Price Target Increase from TD Cowen","media":"Stock Track","content":"<p>Vera Therapeutics, Inc. (VERA) stock soared 5.21% in intraday trading on Wednesday, following a Buy rating and price target increase from TD Cowen analyst Ritu Baral.</p>\n\n<p>In a research report released today, Baral maintained a Buy rating on VERA and raised the price target, citing the company's promising drug pipeline and potential for significant growth. The analyst's positive outlook on VERA's prospects has boosted investor confidence, driving the stock price higher.</p>\n\n<p>Vera Therapeutics is a biopharmaceutical company focused on developing innovative therapies for various diseases. The company's drug candidates have shown promising results in clinical trials, leading analysts to be optimistic about their future success.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Vera Therapeutics Soars 5.21% on Buy Rating and Price Target Increase from TD Cowen</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Vera Therapeutics Soars 5.21% on Buy Rating and Price Target Increase from TD Cowen\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-03-06 04:54</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Vera Therapeutics, Inc. (VERA) stock soared 5.21% in intraday trading on Wednesday, following a Buy rating and price target increase from TD Cowen analyst Ritu Baral.</p>\n\n<p>In a research report released today, Baral maintained a Buy rating on VERA and raised the price target, citing the company's promising drug pipeline and potential for significant growth. The analyst's positive outlook on VERA's prospects has boosted investor confidence, driving the stock price higher.</p>\n\n<p>Vera Therapeutics is a biopharmaceutical company focused on developing innovative therapies for various diseases. The company's drug candidates have shown promising results in clinical trials, leading analysts to be optimistic about their future success.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"VERA","symbol_name":"Vera Therapeutics, Inc.","start_time":0,"source_url":"","article_id":"1132052591","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1132052591","pubTimestamp":1741208059,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Vera Therapeutics, Inc.  stock soared 5.21% in intraday trading on Wednesday, following a Buy rating and price target increase from TD Cowen analyst Ritu Baral.In a research report released today, Baral maintained a Buy rating on VERA and raised the price target, citing the company's promising drug pipeline and potential for significant growth. The analyst's positive outlook on VERA's prospects has boosted investor confidence, driving the stock price higher.Vera Therapeutics is a biopharmaceutic","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"VERA":"Vera Therapeutics, Inc."},"translate_title":"TD Cowen给予Vera Therapeutics买入评级并上调目标价，股价飙升5.21%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VERA":1},"content_text":"Vera Therapeutics, Inc. (VERA) stock soared 5.21% in intraday trading on Wednesday, following a Buy rating and price target increase from TD Cowen analyst Ritu Baral.\nIn a research report released today, Baral maintained a Buy rating on VERA and raised the price target, citing the company's promising drug pipeline and potential for significant growth. The analyst's positive outlook on VERA's prospects has boosted investor confidence, driving the stock price higher.\nVera Therapeutics is a biopharmaceutical company focused on developing innovative therapies for various diseases. The company's drug candidates have shown promising results in clinical trials, leading analysts to be optimistic about their future success.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}